Concepedia

Xingyuan Wang

XW

16

Publications

862

Citations

13

H-Index

2002

Active since

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Jiangsu Hengrui Medicine (China)

Harbin Medical University

First Affiliated Hospital of Harbin Medical University

Ningbo University

Xingyuan Wang is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, tumor immunology, and tumor immunity.

Top concepts

Publications per year

2002–2022

16

Publications

16

Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma

Jing Huang, Binghe Xu, Hongnan Mo et al. · Clinical Cancer Research · 2018 · 216 citations

Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study

Hongnan Mo, Jing Huang, Jiachen Xu et al. · British Journal of Cancer · 2018 · 156 citations · Full text

Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma

Bo Zhang, Ling Qi, Xi Wang et al. · Cancer Communications · 2020 · 135 citations · Full text

Promising efficacy of SHR‐1210, a novel anti–programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China

Jing Huang, Hongnan Mo, Weilong Zhang et al. · Cancer · 2018 · 66 citations · Full text

Bladder cancer cells induce immunosuppression of T cells by supporting PD‐L1 expression in tumour macrophages partially through interleukin 10

Xingyuan Wang, Shaobin Ni, Qi-Yin Chen et al. · Cell Biology International · 2016 · 49 citations

, , +15

Rows per page

1–5 of 16